Dainippon Sumitomo Pharma Co Ltd, 10% Owner at Myovant Sciences Ltd. (MYOV), bought 140,000 shares at $7.65 ($1.1M) on 2020-03-30, disclosed to the SEC on 2020-04-01.
Open-market purchase of $1.1M MYOV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.65 | 70,000 | $536K | 49.0% |
| 2 | $7.97 | 70,000 | $558K | 51.0% |
| Total | $7.81 avg | 140,000 | $1.1M | 100% |
| Filing → |
| MYOV | BUY | 2021-09-01 | $4.3M | — | Filing → |
| MYOV | BUY | 2021-08-20 | $2.7M | — | Filing → |
| MYOV | BUY | 2021-08-18 | $3.0M | — | Filing → |